O

OncoMyx Therapeutics

11 employees

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
multiple myeloma
lung metastasis
sarcoma
ovarian cancer
drug development
Oncology
lung cancer
medical oncology
Health Diagnostics
hematology
acute myeloid leukemia
virology
oncolytic virus
bladder cancer
immunotherapy
Therapeutics
w
Medical

Date founded

2018

Funding rounds raised

Total raised

$50M

from 8 investors over 8 rounds

O

OncoMyx Therapeutics raised $50M on December 9, 2021

Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, City Hill Ventures, Madison Partners, Xeraya Capital, Lumira Ventures and B Capital Group

FAQ